Toby Maher, MBBS, MSc, PhD is Professor of Clinical Medicine and Director of Interstitial Lung Disease at the Keck School of Medicine of the University of Southern California. Previously he was the British Lung Foundation Chair in Respiratory Research and National Institute for Health Research (NIHR) Clinician Scientist. He was Professor of Interstitial Lung Disease and headed up the Fibrosis Research Group at the National Heart and Lung Institute, Imperial College, London. Prof Maher’s research interests include basic and translational research into idiopathic pulmonary fibrosis, with a major focus on biomarker discovery, early phase clinical trials and the pre-clinical validation of putative targets and compound for the treatment of fibrosing lung disease. Prof. Maher qualified from Southampton Medical School. He trained in Respiratory Medicine at the Royal Brompton Hospital. During his training he gained an MSc in Respiratory Medicine from Imperial College London. In 2005 Dr Maher was awarded a Wellcome Trust Clinical Research Fellowship undertaken at the Centre for Respiratory Research, University College London and culminated in the award of a PhD.
